Regeneron Pharmaceuticals, Inc. (REGN)
REGN price $806.58 -0.90 -0.11%
- Ticker
- REGN
- Price
- $806.58
- Change
- -0.90 -0.11%
- Market cap
- $83.04B
- P/E
- 19.28
- Forward P/E
- 13.62
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 55
Regeneron Pharmaceuticals, Inc. is a global biopharmaceutical enterprise focused on discovering, inventing, developing, manufacturing, and bringing to market medical treatments for a wide array of illnesses. Its therapeutic portfolio includes EYLEA, an injection used to treat various ophthalmic conditions such as wet age-related macular degeneration, diabetic macular edema, myopic choroidal neovascularization…